128 related articles for article (PubMed ID: 37433700)
41. Using recursive partitioning approach to select tumor-associated antigens in immunodiagnosis of gastric adenocarcinoma.
Qin J; Wang S; Shi J; Ma Y; Wang K; Ye H; Zhang X; Wang P; Wang X; Song C; Dai L; Wang K; Jiang B; Zhang J
Cancer Sci; 2019 Jun; 110(6):1829-1841. PubMed ID: 30950146
[TBL] [Abstract][Full Text] [Related]
42. MicroRNA-155 acts as a diagnostic and prognostic biomarker for oesophageal squamous cell carcinoma.
Zheng YJ; Liang TS; Wang J; Zhao JY; Zhai SN; Yang DK; Wang LD
Artif Cells Nanomed Biotechnol; 2020 Dec; 48(1):977-982. PubMed ID: 32573268
[TBL] [Abstract][Full Text] [Related]
43. Clinical Value of Serum p53 Antibody in the Diagnosis and Prognosis of Esophageal Squamous Cell Carcinoma.
Kunizaki M; Hamasaki K; Wakata K; Tobinaga S; Sumida Y; Hidaka S; Yasutake T; Miyazaki T; Matsumoto K; Yamasaki T; Sawai T; Hamamoto R; Nanashima A; Nagayasu T
Anticancer Res; 2018 Mar; 38(3):1807-1813. PubMed ID: 29491120
[TBL] [Abstract][Full Text] [Related]
44. Human Proteome Microarray identifies autoantibodies to tumor-associated antigens as serological biomarkers for the diagnosis of hepatocellular carcinoma.
Yang Q; Ye H; Sun G; Wang K; Dai L; Qiu C; Shi J; Zhu J; Wang X; Wang P
Mol Oncol; 2023 May; 17(5):887-900. PubMed ID: 36587394
[TBL] [Abstract][Full Text] [Related]
45. Diagnostic value of serum tumor-associated autoantibodies in esophageal cancer.
Xiao K; Ma X; Wang Y; Zhu C; Guo L; Lu R
Biomark Med; 2021 Oct; 15(15):1333-1343. PubMed ID: 34541870
[No Abstract] [Full Text] [Related]
46. Serum anti-SPP1 autoantibody as a potential novel biomarker in detection of esophageal squamous cell carcinoma.
Wang C; Sun G; Wang H; Dai L; Zhang J; Du R
BMC Cancer; 2022 Aug; 22(1):932. PubMed ID: 36038839
[TBL] [Abstract][Full Text] [Related]
47. Serum anti-TOPO48 autoantibody as a biomarker for early diagnosis and prognosis in patients with esophageal squamous cell carcinoma.
Zhang JB; Cao M; Chen J; Ye SR; Xie K; He X; Ma XL; Zhang J; Yie SM
Clin Res Hepatol Gastroenterol; 2018 Jun; 42(3):276-284. PubMed ID: 29170084
[TBL] [Abstract][Full Text] [Related]
48. A panel of autoantibodies as potential early diagnostic serum biomarkers in patients with cervical cancer.
Huangfu M; Xu S; Li S; Sun B; Lee KH; Liu L; Sun S
Tumour Biol; 2016 Jul; 37(7):8709-14. PubMed ID: 26738866
[TBL] [Abstract][Full Text] [Related]
49. Serum Autoantibodies against STIP1 as a Potential Biomarker in the Diagnosis of Esophageal Squamous Cell Carcinoma.
Xu YW; Liu CT; Huang XY; Huang LS; Luo YH; Hong CQ; Guo HP; Xu LY; Peng YH; Li EM
Dis Markers; 2017; 2017():5384091. PubMed ID: 28852266
[TBL] [Abstract][Full Text] [Related]
50. Serum autoantibodies against a panel of 15 tumor-associated antigens in the detection of ovarian cancer.
Sun H; Shi JX; Zhang HF; Xing MT; Li P; Dai LP; Luo CL; Wang X; Wang P; Ye H; Li LX; Zhang JY
Tumour Biol; 2017 Jun; 39(6):1010428317699132. PubMed ID: 28618923
[TBL] [Abstract][Full Text] [Related]
51. Targeted bisulfite sequencing identified a panel of DNA methylation-based biomarkers for esophageal squamous cell carcinoma (ESCC).
Pu W; Wang C; Chen S; Zhao D; Zhou Y; Ma Y; Wang Y; Li C; Huang Z; Jin L; Guo S; Wang J; Wang M
Clin Epigenetics; 2017; 9():129. PubMed ID: 29270239
[TBL] [Abstract][Full Text] [Related]
52. The diagnostic value of long non-coding RNA MIR31HG and its role in esophageal squamous cell carcinoma.
Sun K; Zhao X; Wan J; Yang L; Chu J; Dong S; Yin H; Ming L; He F
Life Sci; 2018 Jun; 202():124-130. PubMed ID: 29605445
[TBL] [Abstract][Full Text] [Related]
53. Evaluating a Panel of Autoantibodies Against Tumor-Associated Antigens in Human Osteosarcoma.
Luo M; Wu S; Ma Y; Liang H; Luo Y; Gu W; Fan L; Hao Y; Li H; Xing L
Front Genet; 2022; 13():872253. PubMed ID: 35547257
[No Abstract] [Full Text] [Related]
54. Circulating levels of autoantibodies against L1-cell adhesion molecule as a potential diagnostic biomarker in esophageal squamous cell carcinoma.
Xu YW; Peng YH; Ran LQ; Zhai TT; Guo HP; Qiu SQ; Chen HL; Wu ZY; Li EM; Xie JJ
Clin Transl Oncol; 2017 Jul; 19(7):898-906. PubMed ID: 28181176
[TBL] [Abstract][Full Text] [Related]
55. Autoantibodies against tumor-associated antigens in the early detection of lung cancer.
Dai L; Tsay JC; Li J; Yie TA; Munger JS; Pass H; Rom WN; Zhang Y; Tan EM; Zhang JY
Lung Cancer; 2016 Sep; 99():172-9. PubMed ID: 27565936
[TBL] [Abstract][Full Text] [Related]
56. Evaluation of diagnostic value in using a panel of multiple tumor-associated antigens for immunodiagnosis of cancer.
Wang P; Song C; Xie W; Ye H; Wang K; Dai L; Zhang Y; Zhang J
J Immunol Res; 2014; 2014():512540. PubMed ID: 24822225
[TBL] [Abstract][Full Text] [Related]
57. Diagnostic Value of Autoantibodies against Ezrin in Esophageal Squamous Cell Carcinoma.
Li L; Liu M; Lin JB; Hong XB; Chen WX; Guo H; Xu LY; Xu YW; Li EM; Peng YH
Dis Markers; 2017; 2017():2534648. PubMed ID: 28298808
[TBL] [Abstract][Full Text] [Related]
58. Upregulation of Centromere Proteins as Potential Biomarkers for Esophageal Squamous Cell Carcinoma Diagnosis and Prognosis.
Wang X; Lai M; Wang Y; Chai R; Li N; Ou L; Zheng K; Li J; Xu G; Wang S; Dong Y; Wang S
Biomed Res Int; 2022; 2022():3758731. PubMed ID: 35496042
[TBL] [Abstract][Full Text] [Related]
59. Integrated bioinformatics analysis of differentially expressed genes and immune cell infiltration characteristics in Esophageal Squamous cell carcinoma.
Feng Z; Qu J; Liu X; Liang J; Li Y; Jiang J; Zhang H; Tian H
Sci Rep; 2021 Aug; 11(1):16696. PubMed ID: 34404882
[TBL] [Abstract][Full Text] [Related]
60. Discovery and Validation of a Serologic Autoantibody Panel for Early Diagnosis of Esophageal Squamous Cell Carcinoma.
Pan J; Zheng QZ; Li Y; Yu LL; Wu QW; Zheng JY; Pan XJ; Xie BS; Wu YA; Qian J; Zhu H; Huang Y
Cancer Epidemiol Biomarkers Prev; 2019 Sep; 28(9):1454-1460. PubMed ID: 31239266
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
